diff --git a/domains/grand-strategy/ai-governance-discourse-capture-by-competitiveness-framing-inverts-china-us-participation-patterns.md b/domains/grand-strategy/ai-governance-discourse-capture-by-competitiveness-framing-inverts-china-us-participation-patterns.md new file mode 100644 index 000000000..dd124a50e --- /dev/null +++ b/domains/grand-strategy/ai-governance-discourse-capture-by-competitiveness-framing-inverts-china-us-participation-patterns.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: grand-strategy +description: The Paris Summit's framing shift from 'AI Safety' to 'AI Action' and China's signature alongside US/UK refusal reveals that the US now perceives international AI governance as a competitive constraint rather than a tool to limit adversaries +confidence: experimental +source: Paris AI Action Summit outcomes, EPC framing analysis ('Au Revoir, global AI Safety') +created: 2026-04-03 +title: AI governance discourse has been captured by economic competitiveness framing, inverting predicted participation patterns where China signs non-binding declarations while the US opts out +agent: leo +scope: causal +sourcer: EPC, Elysée, Future Society +related_claims: ["definitional-ambiguity-in-autonomous-weapons-governance-is-strategic-interest-not-bureaucratic-failure-because-major-powers-preserve-programs-through-vague-thresholds.md"] +--- + +# AI governance discourse has been captured by economic competitiveness framing, inverting predicted participation patterns where China signs non-binding declarations while the US opts out + +The Paris Summit's official framing as the 'AI Action Summit' rather than continuing the 'AI Safety' language from Bletchley Park and Seoul represents a narrative shift toward economic competitiveness. The EPC titled their analysis 'Au Revoir, global AI Safety?' to capture this regression. Most significantly, China signed the declaration while the US and UK did not—the inverse of what most analysts would have predicted based on the 'AI governance as restraining adversaries' frame that dominated 2023-2024 discourse. The UK's explicit statement that the declaration didn't 'sufficiently address harder questions around national security' reveals that frontier AI nations now view international governance frameworks as competitive constraints on their own capabilities rather than mechanisms to limit rival nations. This inversion—where China participates in non-binding governance while the US refuses—demonstrates that competitiveness framing has displaced safety framing as the dominant lens through which strategic actors evaluate international AI governance. The summit 'noted' previous voluntary commitments rather than establishing new ones, confirming the shift from coordination-seeking to coordination-avoiding behavior by the most advanced AI nations. diff --git a/domains/grand-strategy/international-ai-governance-stepping-stone-theory-fails-because-strategic-actors-opt-out-at-non-binding-stage.md b/domains/grand-strategy/international-ai-governance-stepping-stone-theory-fails-because-strategic-actors-opt-out-at-non-binding-stage.md new file mode 100644 index 000000000..66ca4418b --- /dev/null +++ b/domains/grand-strategy/international-ai-governance-stepping-stone-theory-fails-because-strategic-actors-opt-out-at-non-binding-stage.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: grand-strategy +description: The Paris Summit (February 2025) demonstrated that the US and UK will not sign even non-binding international AI governance frameworks, eliminating the incremental path to binding commitments +confidence: experimental +source: Paris AI Action Summit (February 2025), EPC analysis, UK government statement +created: 2026-04-03 +title: International AI governance stepping-stone theory (voluntary → non-binding → binding) fails because strategic actors with frontier AI capabilities opt out even at the non-binding declaration stage +agent: leo +scope: structural +sourcer: EPC, Future Society, Amnesty International +related_claims: ["eu-ai-act-article-2-3-national-security-exclusion-confirms-legislative-ceiling-is-cross-jurisdictional.md", "the-legislative-ceiling-on-military-ai-governance-is-conditional-not-absolute-cwc-proves-binding-governance-without-carveouts-is-achievable-but-requires-three-currently-absent-conditions.md"] +--- + +# International AI governance stepping-stone theory (voluntary → non-binding → binding) fails because strategic actors with frontier AI capabilities opt out even at the non-binding declaration stage + +The Paris AI Action Summit (February 10-11, 2025) produced a declaration signed by 60 countries including China, but the US and UK declined to sign. The UK explicitly stated the declaration didn't 'provide enough practical clarity on global governance' and didn't 'sufficiently address harder questions around national security.' This represents a regression from the Bletchley Park (November 2023) and Seoul (May 2024) summits, which at least secured voluntary commitments that Paris could only 'note' rather than build upon. The stepping-stone theory assumes that voluntary commitments create momentum toward non-binding declarations, which then enable binding treaties. Paris demonstrates this theory fails at the second step: the two countries with the most advanced frontier AI development (US and UK) will not participate even in non-binding frameworks. The summit produced 'no new binding commitments' and 'no substantial commitments to AI safety' despite the publication of the International AI Safety Report 2025. This is structural evidence that strategic actor opt-out extends to all levels of international AI governance, not just binding treaties. diff --git a/domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md b/domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md new file mode 100644 index 000000000..ad9c946ae --- /dev/null +++ b/domains/health/glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: The access barrier is not random but systematically concentrated away from high-risk populations, with California Medi-Cal ending weight-loss coverage January 2026 despite strongest clinical evidence for cardiovascular benefit +confidence: experimental +source: ICER White Paper, April 2025; California Medi-Cal policy change effective January 1, 2026 +created: 2026-04-03 +title: "GLP-1 anti-obesity drug access is structurally inverted: populations with greatest cardiovascular mortality risk face the highest costs and lowest coverage rates, preventing clinical efficacy from reaching population-level impact" +agent: vida +scope: structural +sourcer: Institute for Clinical and Economic Review (ICER) +related_claims: ["[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]", "[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]"] +--- + +# GLP-1 anti-obesity drug access is structurally inverted: populations with greatest cardiovascular mortality risk face the highest costs and lowest coverage rates, preventing clinical efficacy from reaching population-level impact + +ICER's 2025 access analysis reveals a structural inversion: the populations with greatest cardiovascular mortality risk (lower SES, Black Americans, Southern rural residents) face the highest out-of-pocket costs and lowest insurance coverage rates for GLP-1 anti-obesity medications. In Mississippi, continuous GLP-1 treatment costs approximately 12.5% of annual income for the typical individual. Only 19% of US employers with 200+ workers cover GLP-1s for weight loss (2025 data). Most critically, California Medi-Cal—the largest state Medicaid program—ended coverage of GLP-1 medications prescribed solely for weight loss effective January 1, 2026, exactly when clinical evidence for cardiovascular mortality benefit is strongest (SELECT trial FDA approval March 2024). This is not a temporary access gap but a structural misalignment: the regulatory/coverage system is moving opposite to the clinical evidence direction. The drugs have proven individual-level efficacy for cardiovascular mortality reduction, but access concentration in low-risk, higher-income populations means clinical efficacy cannot translate to population-level impact on the timeline suggested by individual trial results. This explains the RGA 2045 projection for population-level mortality impact despite 2024 clinical proof of individual benefit. diff --git a/entities/grand-strategy/paris-ai-action-summit.md b/entities/grand-strategy/paris-ai-action-summit.md new file mode 100644 index 000000000..6504121d3 --- /dev/null +++ b/entities/grand-strategy/paris-ai-action-summit.md @@ -0,0 +1,41 @@ +# Paris AI Action Summit + +**Type:** International governance summit +**Date:** February 10-11, 2025 +**Location:** Paris, France +**Host:** French government (Emmanuel Macron) +**Participants:** 100+ countries +**Signatories:** 60 countries (including Canada, China, France, India) +**Notable non-signatories:** United States, United Kingdom + +## Overview + +The Paris AI Action Summit was the third major international AI governance summit following Bletchley Park (November 2023) and Seoul (May 2024). Unlike its predecessors, Paris produced no new binding commitments and could only 'note' the voluntary commitments from previous summits rather than building upon them. + +## Key Outcomes + +- **Declaration:** 60 countries signed, but US and UK declined +- **Binding commitments:** None +- **Safety commitments:** None substantial, despite publication of International AI Safety Report 2025 +- **Framing shift:** From 'AI Safety' (Bletchley/Seoul) to 'AI Action' (economic competitiveness) + +## UK Statement on Non-Participation + +The UK government stated the declaration didn't 'provide enough practical clarity on global governance' and didn't 'sufficiently address harder questions around national security and the challenge that AI poses to it.' + +## Analysis + +The European Policy Centre titled their analysis 'Au Revoir, global AI Safety?' to capture the regression from safety-focused to competitiveness-focused framing. The summit represents a potential endpoint for the international AI safety governance track that began at Bletchley Park. + +## Timeline + +- **2025-02-10** — Summit begins with 100+ country participation +- **2025-02-11** — Declaration released with 60 signatories; US and UK decline to sign +- **2025-02-11** — EPC publishes analysis framing summit as end of global AI safety coordination + +## Sources + +- https://www.epc.eu/publication/The-Paris-Summit-Au-Revoir-global-AI-Safety-61ea68/ +- https://www.elysee.fr/en/emmanuel-macron/2025/02/11/statement-on-inclusive-and-sustainable-artificial-intelligence-for-people-and-the-planet +- https://thefuturesociety.org/aiactionsummitvspublicpriorities/ +- https://www.amnesty.org/en/latest/news/2025/02/global-france-ai-action-summit-must-meaningfully-center-binding-and-enforceable-regulation-to-curb-ai-driven-harms/ \ No newline at end of file diff --git a/inbox/queue/2025-05-20-who-pandemic-agreement-adoption-us-withdrawal.md b/inbox/archive/grand-strategy/2025-05-20-who-pandemic-agreement-adoption-us-withdrawal.md similarity index 98% rename from inbox/queue/2025-05-20-who-pandemic-agreement-adoption-us-withdrawal.md rename to inbox/archive/grand-strategy/2025-05-20-who-pandemic-agreement-adoption-us-withdrawal.md index 1d4998d04..bd83c704c 100644 --- a/inbox/queue/2025-05-20-who-pandemic-agreement-adoption-us-withdrawal.md +++ b/inbox/archive/grand-strategy/2025-05-20-who-pandemic-agreement-adoption-us-withdrawal.md @@ -7,9 +7,12 @@ date: 2025-05-20 domain: grand-strategy secondary_domains: [] format: research-synthesis -status: unprocessed +status: processed +processed_by: leo +processed_date: 2026-04-03 priority: high tags: [who, pandemic-agreement, covid-governance, us-withdrawal, pabs, commercial-blocking, triggering-event] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content diff --git a/inbox/queue/2025-04-09-icer-glp1-access-gap-affordable-access-obesity-us.md b/inbox/archive/health/2025-04-09-icer-glp1-access-gap-affordable-access-obesity-us.md similarity index 98% rename from inbox/queue/2025-04-09-icer-glp1-access-gap-affordable-access-obesity-us.md rename to inbox/archive/health/2025-04-09-icer-glp1-access-gap-affordable-access-obesity-us.md index d7b4d9711..7b2fb3e3f 100644 --- a/inbox/queue/2025-04-09-icer-glp1-access-gap-affordable-access-obesity-us.md +++ b/inbox/archive/health/2025-04-09-icer-glp1-access-gap-affordable-access-obesity-us.md @@ -7,9 +7,12 @@ date: 2025-04-09 domain: health secondary_domains: [] format: policy-report -status: unprocessed +status: processed +processed_by: vida +processed_date: 2026-04-03 priority: high tags: [GLP-1, obesity, access, affordability, coverage, Medicaid, equity, belief-1, belief-2, belief-3, structural-barrier] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content